Toxic liver disease with hepatic necrosis, without coma
ICD-10 K71.10 is a billable code used to indicate a diagnosis of toxic liver disease with hepatic necrosis, without coma.
Toxic liver disease with hepatic necrosis, without coma, is a serious condition characterized by the destruction of liver cells due to exposure to toxic substances, such as drugs, alcohol, or environmental toxins. Clinically, patients may present with symptoms including jaundice, abdominal pain, nausea, vomiting, and fatigue. The liver, a vital organ in the digestive system, plays a crucial role in metabolizing substances and detoxifying harmful compounds. In cases of hepatic necrosis, the liver's ability to function is severely compromised, leading to potential liver failure if not addressed promptly. Disease progression can vary based on the extent of exposure and individual patient factors, with some patients recovering fully while others may develop chronic liver disease. Diagnostic considerations include a thorough patient history, liver function tests, imaging studies, and possibly a liver biopsy to assess the extent of necrosis. Early recognition and intervention are critical to prevent further liver damage and complications.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
K71.10 covers toxic liver disease resulting in hepatic necrosis due to exposure to harmful substances, excluding cases where the patient is in a coma. This includes drug-induced liver injury and alcohol-related liver damage without severe complications.
K71.10 should be used when there is evidence of hepatic necrosis due to toxins without the presence of coma. If coma is present, K71.11 should be utilized. Accurate assessment of the patient's clinical status is crucial for appropriate code selection.
Documentation should include a detailed patient history of toxin exposure, clinical symptoms, results of liver function tests, imaging studies, and any interventions performed. Clear documentation of the absence of coma is also necessary.
